Trends in stomach and pancreatic cancer incidence and mortality in England and Wales, 1951-2000

被引:25
作者
Fitzsimmons, D.
Osmond, C.
George, S.
Johnson, C. D.
机构
[1] Southampton Gen Hosp, Univ Surg Unit, Southampton SO16 6YD, Hants, England
[2] Univ Coll Swansea, Sch Hlth Sci, Swansea, W Glam, Wales
[3] Southampton Gen Hosp, MRC, Epidemiol Resource Ctr, Southampton SO9 4XY, Hants, England
[4] Southampton Gen Hosp, Hlth Care Res Unit, Southampton SO9 4XY, Hants, England
基金
英国医学研究理事会;
关键词
D O I
10.1002/bjs.5751
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The aim of this study was to describe period and cohort effects in incidence and mortality of stomach and pancreatic cancer in England and Wales. Methods: National figures for mortality (1951-2000) and incidence (1971-2000) were analysed using log-linear Poisson regression models to obtain relative risks (RR) for period (year of incidence or death) and cohort (year of birth). Results: Stomach cancer shows a pronounced cohort effect in mortality with a decline in RR in men from 2.20 (1876) to 0.47 (1946) and a reduction from 2.79 to 0.41 for women. Mortality to incidence ratios are now less than 0.70. Pancreatic cancer mortality (men) RR rose from 0.91 (1951-1955) to a peak 1.11 (1976-1980) and then declined to 0.90 (1996-2000). Women showed a similar pattern. Cohort RR (men) increased to a peak of 1.14 in 1916 and declined to 1.01 in 1946, and continued to fall; the peak occurred slightly later in women. Mortality to incidence ratios were near 1 in the first 20 years, declining to 0.95 in the last 10 years. Conclusion: Stomach cancer incidence has fallen continuously from 19(th) century birth cohorts onwards. Incidence of pancreatic cancer has fallen in successive birth cohorts after 1920; peak period risk was 1976-1990. Age-standardized mortality and case mortality for pancreatic cancer are declining.
引用
收藏
页码:1162 / 1171
页数:10
相关论文
共 50 条
[1]
Ahlgren JD, 1996, SEMIN ONCOL, V23, P241
[2]
Gastric cancer in the European Union (1968-1992): Mortality trends and cohort effect [J].
Aragones, N ;
Pollan, M ;
Rodero, I ;
LopezAbente, G .
ANNALS OF EPIDEMIOLOGY, 1997, 7 (04) :294-303
[3]
Helicobacter pylori - What do we still need to know? [J].
Axon, A .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (01) :15-19
[4]
Influence of specialization on the management and outcome of patients with pancreatic cancer [J].
Bachmann, MO ;
Alderson, D ;
Peters, TJ ;
Bedford, C ;
Edwards, D ;
Wotton, S ;
Harvey, IM .
BRITISH JOURNAL OF SURGERY, 2003, 90 (02) :171-177
[5]
BERRINO F, 1999, IARC SCI PUBLICATION, V151
[6]
RISING INCIDENCE OF ADENOCARCINOMA OF THE ESOPHAGUS AND GASTRIC CARDIA [J].
BLOT, WJ ;
DEVESA, SS ;
KNELLER, RW ;
FRAUMENI, JF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (10) :1287-1289
[7]
Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries [J].
Botterweck, AAM ;
Schouten, LJ ;
Volovics, A ;
Dorant, E ;
van den Brandt, PA .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2000, 29 (04) :645-654
[8]
Boyle P, 1996, INT J CANCER, V67, P63, DOI 10.1002/(SICI)1097-0215(19960703)67:1<63::AID-IJC12>3.0.CO
[9]
2-D
[10]
BRAMHALL S, 1998, PANCREAS, V2, P889